Regeneron Pharmaceuticals, Inc. Share Price

Regeneron Pharmaceuticals, Inc. Share Price

NASDAQ: REGN | Large Cap
$957.38
+$5.78 (0.61%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Regeneron Pharmaceuticals, Inc. Stock Performance

Open
$950.38
Prev. Close
$951.59
Circuit Range
N/A
Day Range
$949.22 - $965.29
Year Range
$591.65 - $988.48
Volume
31,898
Average Traded
$957.33

Regeneron Pharmaceuticals, Inc. Share Price Today

As of 18 November 2026, Regeneron Pharmaceuticals, Inc.'s share price is $957.38. The stock opened at $950.38, compared to its previous close of $951.59. During today's trading session, Regeneron Pharmaceuticals, Inc.'s share price traded between $949.22 and $965.29, with an average price of $957.25. Over the past 52 weeks, the stock has recorded a high of $988.48 and a low of $591.65. In terms of performance, Regeneron Pharmaceuticals, Inc.'s share price has risen by 56.29% over the last six months and is up 22.69% on a year-on-year basis.

Regeneron Pharmaceuticals, Inc. Share Price Chart

Line chart of the Regeneron Pharmaceuticals, Inc. price trend over the selected period. The price rose overall, ranging from 949.45 to 965.13, ending at 957.65.
$949.22$965.29
L
Show Current Price
H

Regeneron Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$100.14B
PE Ratio (TTM)
20.45
Dividend Yield
0.39%
EPS (TTM)
$46.57
Revenue (TTM)
$14.34B
Return On Equity (TTM)
14.38%
Profit Margin
31.38%
Debt to Equity
0.08
Quarterly Earnings Growth YoY
130.72%

Regeneron Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$3884.30$3605.40$4290.70$5115.80
Net Profit$844.60$727.20$1296.90$1948.70
Net Profit Margin21.74%20.17%30.23%38.09%
Income ChangeN/A-13.90%78.34%50.26%

Regeneron Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$12.17$13.12$14.20$14.34
Net Profit$4.34$3.95$4.41$4.50
Net Profit Margin35.66%30.11%31.06%31.38%
Income ChangeN/A-8.99%11.65%2.04%

About Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Regeneron Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$933.95
$957.69
+3.24%
Oct 2026
$764.75
$927.66
+22.23%
Sep 2026
$805.30
$758.94
-6.03%
Aug 2026
$769.52
$807.67
+5.89%
Jul 2026
$629.90
$762.72
+22.33%
Jun 2026
$608.49
$623.51
+1.79%
May 2026
$702.85
$612.54
-13.37%
Apr 2026
$775.78
$707.12
-8.44%
Mar 2026
$772.50
$772.33
-1.17%
Feb 2026
$734.75
$781.47
+5.38%
Jan 2026
$772.51
$741.55
-3.93%
Dec 2025
$775.60
$771.86
-1.09%

REGN Share Price FAQs